PRECISION POPULATION HEALTH

The NIH-funded network will implement and scale population-based genomic screening for common, actionable conditions in 25,000 adults in primary care settings across the U.S.  Researchers at Ariadne Labs, a joint center for health systems innovation at Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health, and partner institutions have received a… Continue reading Ariadne Labs and Collaborators Receive NIH Funding to Launch Major National Study Advancing Population Genomic Screening in Primary Care

Six states and one U.S. territory selected to assess feasibility of integrating whole genome sequencing into public health newborn screening Boston, MA Investigators leading BEACONS (Building Evidence and Collaboration for GenOmics in Nationwide Newborn Screening) today announced two major milestones in an NIH-funded research effort to evaluate genomic newborn screening: the selection of participating state… Continue reading BEACONS Selects Seven Sites, Finalizes Gene List for Genomic Newborn Screening Study

Announcing the launch of BEACONS (Building Evidence and Collaboration for GenOmics in Nationwide Newborn Screening), the nation’s first multi-state genomic newborn screening initiative.

Dr. Robert Green takes the Ted Talks main stage to talk the future of medicine and genetic sequencing.

MGB coverage on the International Consortium of Newborn Sequencing (ICoNS) publishing of their findings and tool in Genetics in Medicine. They identified key factors influencing gene inclusion in newborn genomic screening programs and the team developed a machine learning model incorporating 13 predictors, achieving high accuracy in predicting gene selection across programs.

Dr. Robert Green pens a commentary in the Chicago Tribune on genetic testing and how some celebrities have raised awareness by sharing their genetic risks publicly.

Dr. Robert Green joins Nightlife with Philip Clark to discuss how precision medicine is changing the way we manage disease.